加速康复外科促进机器人腹腔镜胰岛素瘤摘除术术后的康复

基础医学与临床 ›› 2020, Vol. 40 ›› Issue (4): 543-546.

加速康复外科促进机器人腹腔镜胰岛素瘤摘除术术后的康复

马满姣¹, 张秀华^1*, 刘子嘉¹, 吴文铭², 赵玉沛²

1.中国医学院科学院北京协和医学院北京协和医院麻醉科, 北京 100730;
2.中国医学院科学院北京协和医学院北京协和医院基本外科, 北京 100730

收稿日期:2019-06-10 修回日期:2019-11-05 出版日期:2020-04-05 发布日期:2020-04-06
通讯作者: *zhangxh@pumch.cn

Enhanced recovery after surgery promotes postoperative recovery of patients receiving robot assisted laparoscopic insulinoma enucleation

MA Man-jiao¹, ZHANG Xiu-hua^1*, LIU Zi-jia¹, WU Wen-ming², ZHAO Yu-pei²

1. Department of Anesthesiology Surgery;
2. Department of General Surgery, Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730, China

Received:2019-06-10 Revised:2019-11-05 Online:2020-04-05 Published:2020-04-06
Contact: *zhangxh@pumch.cn

摘要/Abstract

摘要： 目的比较加速康复外科(ERAS)对机器人腹腔镜胰岛素瘤摘除术术后恢复的影响。方法收集北京协和医院2013年1月至2016年3月行该手术患者的临床麻醉资料,比较在2015年采用ERAS策略前后两组患者(常规组和ERAS组)的术后恢复情况。结果 68例患者纳入研究,肥胖率为69.1%。ERAS组的术中输液量较常规组明显减少(P＜0.05),尿量无差异;ERAS组气道峰压最高值低于常规组 (P＜0.05);ERAS组的术后住院时间短于常规组 (P＜0.05),ERAS组术后并发症少见。结论机器人腹腔镜胰岛素瘤患者采用ERAS策略可以缩短术后住院时间,有减少术后并发症的趋势。

关键词: 机器人腹腔镜手术, 胰岛素瘤, 加速康复外科, 肥胖

Abstract: Objective To compare the postoperative recovery of patients receiving robotic laparoscopic insulinoma enucleation before and after implementing enhanced recovery after surgery (ERAS) protocol. Methods Anesthetic data of patients who received robotic laparoscopic insulinoma enucleation from January 2013 to March 2016 in Peking Union Medical College Hospital were collected and analyzed. All patients were be divided into routine group and ERAS group. Results The study enrolled 68 patients, whose obesity rate was 69.1%. The intraoperative fluid volume of ERAS group was lower than that of the routine group (P＜0.05), while the difference of urine output was not significant. The maximum peak airway pressure of ERAS group was also lower than that in the routine group(P＜0.05). The postoperative hospital stay length of ERAS group was shorter (P＜0.05). The postoperative complications were uncommon in the ERAS group. Conclusions ERAS protocol can shorten the hospital stay length of patients receiving robotic laparoscopic insulinoma enuleation and postoperative complications are likely to be reduced.

Key words: robotic surgical system, insulinoma, enhanced recovery after surgery, obesity

中图分类号:

R614.2

马满姣, 张秀华, 刘子嘉, 吴文铭, 赵玉沛. 加速康复外科促进机器人腹腔镜胰岛素瘤摘除术术后的康复[J]. 基础医学与临床, 2020, 40(4): 543-546.

MA Man-jiao, ZHANG Xiu-hua, LIU Zi-jia, WU Wen-ming, ZHAO Yu-pei. Enhanced recovery after surgery promotes postoperative recovery of patients receiving robot assisted laparoscopic insulinoma enucleation[J]. Basic & Clinical Medicine, 2020, 40(4): 543-546.

参考文献

[1]Altman AD, Helpman L, McGee J, et al. Enhanced recovery after surgery: implementing a new standard of surgical care[J]. CMAJ, 2019, 191:E469-E475.
[2]Lassen K, Coolsen MM, Slim K, et al. Guidelines for perioperative care for pancreaticoduodenectomy: enhanced recovery after surgery (ERAS) society recommendations[J]. Clin Nutr, 2012, 31:817-830.
[3]Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review[J]. JAMA Surg, 2017, 152:292-298.
[4]Simpson JC, Bao X, Agarwala A. Pain management in enhanced recovery after surgery (ERAS) protocols[J]. Clin Colon Rectal Surg, 2019, 32:121-128.
[5]Maund E, McDaid C, Rice S, et al. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review[J]. Br J Anaesth, 2011, 106:292-297.
[6]Laks S, Isaak RS, Strassle PD, et al. Increased intraoperative vasopressor use as part of an enhanced recovery after surgery pathway for pancreatectomy does not increase risk of pancreatic fistula[J]. J Pancreat Cancer, 2018, 4:33-40.
[7]Phan TD, D'Souza B, Rattray MJ, et al. A randomised controlled trial of fluid restriction compared to oesophageal doppler-guided goal-directed fluid therapy in elective major colorectal surgery within an enhanced recovery after surgery program[J]. Anaesth Intensive Care, 2014, 42:752-760.
[8]Sierzega M, Choruz R, Pietruszka S, et al. Feasibility and outcomes of early oral feeding after total gastrectomy for cancer[J]. J Gastrointest Surg, 2015, 19:473-479.
[9]Cassidy MR, Rosenkranz P, McAneny D. Reducing postoperative venous thromboembolism complications with a standardized risk-stratified prophylaxis protocol and mobilization program[J]. J Am Coll Surg, 2014, 218:1095-1104.
[10]Short V, Herbert G, Perry R, et al.Chewing gum for postoperative recovery of gastrointestinal function[J]. Cochrane Database Syst Rev, 2015. doi: 10.1002/14651858.CD006506.pub3.

[1]	加孜热亚·再依拿提, 李素丽, 张凯迪, 马福慧, 马国英, 郭艳英. 桥本甲状腺炎中辅助T细胞及其细胞因子与腹型肥胖相关[J]. 基础医学与临床, 2024, 44(8): 1120-1125.
[2]	丁宝锋, 王小爽, 王芳, 余佳. 肥胖模型小鼠肝脏的病理变化及代谢组分析[J]. 基础医学与临床, 2024, 44(5): 699-704.
[3]	张沥元, 杜函泽, 潘慧. 治疗下丘脑性肥胖的药物研究进展[J]. 基础医学与临床, 2024, 44(5): 729-732.
[4]	卢慧莹, 王建国. 下调去甲基化酶FTO抑制人肝癌细胞系HepG2增殖[J]. 基础医学与临床, 2024, 44(2): 185-191.
[5]	朱倩梅, 刘子嘉, 谭刚, 申乐, 黄宇光. 加速康复外科与围术期管理课程在研究生教学中的探索实践[J]. 基础医学与临床, 2024, 44(2): 276-280.
[6]	廖镇城, 杨思懿, 吴平安. 提高m⁶A去甲基化酶FTO表达抑制鼻咽癌细胞增殖[J]. 基础医学与临床, 2024, 44(1): 57-62.
[7]	马国英, 加孜热亚·再依拿提, 李素丽, 郭艳英. 基于血清蛋白质组学分析桥本甲状腺炎合并肥胖患者血清蛋白质差异表达[J]. 基础医学与临床, 2023, 43(9): 1375-1382.
[8]	陈辛, 陈俊, 徐幸, 王旭. 组蛋白去甲基化酶抑制剂GSK-J4减轻高脂诱导的肥胖小鼠体质量[J]. 基础医学与临床, 2023, 43(9): 1353-1358.
[9]	王鑫瑞, 秦燕. Ghrelin在代谢性疾病中作用的研究进展[J]. 基础医学与临床, 2023, 43(8): 1299-1303.
[10]	张晶, 吴凯, 黄伟. 人前体脂肪细胞分化过程及肥胖人群脂肪组织中hsa_circ_0017650高表达[J]. 基础医学与临床, 2023, 43(7): 1079-1083.
[11]	蒋晨晨, 崔泽, 潘利, 孙纪新, 何慧婧, 胡耀达, 单广良. 河北省汉族和满族成人高血压家族史与超重/肥胖对高血压发病的交互作用[J]. 基础医学与临床, 2023, 43(7): 1053-1059.
[12]	董德鑫, 张玉石, 严维刚, 石冰冰. 改良加速康复外科在腹腔镜肾部分切除术中的应用[J]. 基础医学与临床, 2023, 43(11): 1702-1706.
[13]	李瑜, 张雯, 袁昱, 李姝亭, 王哲, 贲亚琍, 戴飏. 小鼠内源性逆转录病毒Gag抗原在胰岛的表达及单克隆抗体的制备[J]. 基础医学与临床, 2023, 43(1): 59-67.
[14]	胡诗琪, 蓝彦琦, 吴寿岭, 王晓墨, 陈朔华, 汪国栋, 王丽. 肥胖及其变化对中国华北新发NAFLD成年男性患者心血管疾病发病风险的影响[J]. 基础医学与临床, 2022, 42(5): 788-794.
[15]	李妍, 刘陶迪, 周好乐. TRIB3在肥胖发生中作用的研究进展[J]. 基础医学与临床, 2021, 41(9): 1352-1355.